Increased blood pressure after abrupt cessation of daily cannabis use

J Addict Med. 2011 Mar;5(1):16-20. doi: 10.1097/ADM.0b013e3181d2b309.

Abstract

Objective: Cannabis is the most widely used illicit drug. Acute cannabis administration increases blood pressure (BP) and heart rate and tolerance develops to these effects with heavy use. A valid and reliable withdrawal syndrome occurs in most daily users, but few studies have assessed the cardiovascular effects of withdrawal. The objective of this report is to describe unexpected changes in cardiovascular function during brief periods of supervised cannabis use and abstinence in daily cannabis users.

Methods: A within-subjects ABAC crossover study in which inpatient volunteers smoked cannabis ad libitum (A), and abstained from cannabis (B/C). Vital signs were obtained 3 times daily during 11 inpatient days for 13 daily cannabis users (11 men, 8 African American).

Results: BP increased significantly during periods of cannabis abstinence compared with periods of cannabis use. The magnitude of increase was substantial in a subset (N = 6) of participants, with mean increases of up to 22.8 mm Hg systolic and 12.3 mm Hg diastolic BP observed. A main effect of heart rate was not observed. Secondary analysis limited to morning assessments suggested that resting heart rate increased during abstinence, but the magnitude of this effect was not clinically significant.

Conclusions: Abrupt cessation of heavy cannabis use may cause clinically significant increases in BP in a subset of users. BP should be monitored among those attempting to reduce or quit frequent cannabis use, particularly those with preexisting hypertension. The time course of this effect is currently unknown and requires further study.

Trial registration: ClinicalTrials.gov NCT00893269.

Keywords: Blood Pressure; Cannabis; Hypertension; Marijuana; Withdrawal.

Publication types

  • Controlled Clinical Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Blood Pressure / drug effects*
  • Cross-Over Studies
  • Dronabinol / adverse effects*
  • Female
  • Heart Rate / drug effects
  • Humans
  • Hypnotics and Sedatives / therapeutic use*
  • Male
  • Marijuana Abuse / rehabilitation*
  • Pyridines / therapeutic use*
  • Substance Withdrawal Syndrome / diagnosis*
  • Zolpidem

Substances

  • Hypnotics and Sedatives
  • Pyridines
  • Dronabinol
  • Zolpidem

Associated data

  • ClinicalTrials.gov/NCT00893269